Disease assessment in Behçet's disease

Behçet's Syndrome

Volumn , Issue , 2010, Pages 299-315

  Mumcu, Gonca ^c   Yazící, Yusuf ^a   Chamberlain, M Anne ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c MARMARA UNIVERSITY   (Turkey)

Author keywords

Beh et's disease; Disease activity; Indices; Measurement; Oral health; Quality of life

Indexed keywords

EID: 84869997613     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-5641-5_18     Document Type: Chapter

References (34)

1. Sut N, Seyahi E, Yurdakul S, Senocak M, Yazici H (2007) A cost analysis of Behçet's syndrome in Turkey. Rheumatology (Oxford) 46:678-682 (Pubitemid 46523316)
2. Prevoo ML, Van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44-48
3. Yazici H, Tuzun Y, Pazarli H, Yurdakul S, Ozyazgan Y, Ozdogan H, Serdaroglu S, Ersanli M, Ulkü BY, Müftüoǧlu AU (1984) Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome. Ann Rheum Dis 43:783-789 (Pubitemid 15190181)
4. Lawton G, Bhakta BB, Chamberlain MA, Tennant A (2004) The Behçet's disease activity index. Rheumatology (Oxford) 43:73-78
5. Beaton DE (2000) Understanding the relevance of measured change through studies of responsiveness. Spine 25:3192-3199 (Pubitemid 32042952)
6. Lee ES, Kim HS, Bang D, Yu HG, Chung H, Shin DH, Song YW, Park YB, Lee SK, Shin SK, Kim WH, Choi J, Park BJ, Lee S (2003) (2003) Development of clinical activity form for Korean patients with Behçet's disease. Adv Exp Med Biol 528:153-156 (Pubitemid 41582756)
7. Neves FS, Moraes JC, Kowalski SC, Goldenstein-Schainberg C, Lage LV, Gonçalves CR (2007) Cross-cultural adaptation of the Behçet's Disease Current Activity Form (BDCAF) to Brazilian Portuguese language. Clin Rheumatol 26:1263-1267 (Pubitemid 47034180)
8. Hamuryudan V, Fresko I, Direskeneli H, Tenant MJ, Yurdakul S, Akoglu T, Yazici H (1999) Evaluation of the Turkish translation of a disease activity form for Behçet's syndrome. Rheumatology (Oxford) 38:734-736 (Pubitemid 29507390)
9. Forbess C, Swearingen C, Yazici Y (2008) Behçet's Syndrome Activity Score (BSAS): a new disease activity assessment tool, composed of patient-derived measures only, is strongly correlated with The Behçet's Disease Current Activity Form (BDCAF). Ann Rheum Dis 67(SII):360
10. Shahram F, Khabbazi A, Nadji A, Ziaie N, Banihashemi AT, Davatchi F (2009) Comparison of existing disease activity indices in the follow-up of patients with Behçet's disease. Mod Rheumatol 19(5):536-541
11. Simsek I, Meric C, Erdem H, Pay S, Kilic S, Dinc A (2008) Accuracy of recall of the items included in disease activity forms of Behçet's disease: comparison of retrospective questionnaires with a daily telephone interview. Clin Rheumatol 27:1255-1260
12. Bang D, Kim HS, Lee ES, Lee S (2000) The significance of laboratory test in evaluating the clinical activity of Behçet's disease. In: Proceedings of the 9th international conference in Behçet's disease held in Seoul, Korea, 27-29 May
13. Deuter C M E, Kotter I, Gunaydin I, Zierhut M, Stubiger N (2004) Ocular involvement in Behçet's disease: first 5-year-results for visual development after treatment with interferon alfa-2a. Ophthalmologe 101:129-134 (Pubitemid 38295555)
14. Amberger M, Groll S, Günaydin I, Deuter C, Vonthein R, Kötter I (2007) Intracellular cytokine patterns in Behçet's disease in comparison to ankylosing spondylitis-influence of treatment with interferon-alpha2a. Clin Exp Rheumatol 25(Suppl 45):S52-S57
15. Kötter I, Koch S, Vonthein R, Rückwaldt U, Amberger M, Günaydin I, Zierhut M, Stübiger N (2005) Cytokines, cytokine antagonists and soluble adhesion molecules in patients with ocular Behçet's disease treated with human recombinant interferon-alpha2a. Results of an open study and review of the literature. Clin Exp Rheumatol 23(Suppl 38):S20-S26
16. Cekmen M, Evereklioglu C, Er H, Inaloz HS, Doganay S, Yurkoz Y, Ozerol IH (2003) Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet's syndrome. Int J Dermatol 42(11):870-875 (Pubitemid 37441452)
17. Nanke Y, Kotake S, Goto M, Ujihara H, Matsubara M, Kamatani N (2008) Decreased percentages of regulatory T cells in peripheral blood of patients with Behçet's disease before ocular attack: a possible predictive marker of ocular attack. Mod Rheumatol 18(4):354-358
18. Pay S, Abbasov T, Erdem H, Musabak U, Simsek I, Pekel A, Akdogan A, Sengul A, Dinc A (2007) Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation? Clin Exp Rheumatol 25(Suppl 45):S-70-S-75
19. Tugal-Tutkun I, Herbort CP, Khairallah M (2008) The Angiography Scoring for Uveitis Working Group (ASUWOG). Scoring of dual fluorescein and ICG inflammatory angiographic signs for the grading of posterior segment inflammation (dual fluorescein and ICG angiographic scoring system for uveitis). Int Ophthalmol Sep. 16. [Epub ahead of print]
20. Mumcu G, Ergun T, Inanc N, Fresko I, Atalay T, Hayran O, Direskeneli H (2004) Oral health is impaired in Behçet's disease and is associated with disease severity. Rheumatology (Oxford) 43:1028-1033 (Pubitemid 39144451)
21. Mumcu G, Sur H, Inanç N, Karacayli U, Cimilli H, Sisman N, Ergun T, Direskeneli H (2009) A composite index for determining the impact of oral ulcer activity in Behçet's disease and recurrent aphthous stomatitis. J Oral Pathol Med 38:785-791
22. Mumcu G, Inanc N, Ergun T, Ikiz K, Gunes M, Islek U, Yavuz S, Sur H, Atalay T, Direskeneli H (2006) Oral health related quality of life is affected by disease activity in Behçet's disease. Oral Dis 12:145-151
23. Mumcu G, Hayran O, Ozalp Do, Inanc N, Yavuz S, Ergun T, Direskeneli H (2007) The assessment of oral health related quality of life by factor analysis in patients with Behçet's disease and recurrent apthous stomatitis. J Oral Pathol Med 36:147-152
24. McGrath C, Hegarty AM, Hodgson TA, Porter SR (2003) Patient-centered outcome measures for oral mucosal disease are sensitive to treatment. Int J Oral Maxillofac Surg 32:334-336 (Pubitemid 36700744)
25. Mumcu G (2008) Behçet's disease: a dentist's overview. Clin Exp Rheumatol 26(Suppl 50):S121-S124
26. Hatemi G, Silman A, Dang B, Bodaghi B, Chamberlain AM, Gul A, Houman MH, Kötter I, Olivieri I, Salvarani C, Sfikakis PP, Siva A, Stanford MR, Stübiger N, Yurdakul S, Yazici H (2008) EULAR recommendation for the management of Behçet's disease. Ann Rheum Dis 67:1656-1662
27. Karacayli U, Mumcu G, Simsek I, Pay S, Kose O, Erdem H, Direskeneli H, Gunaydin Y, Dinc A (2009) The close association between dental and periodontal treatments and oral ulcer course in Behçet's disease: a prospective clinical study. J Oral Pathol Med 38:410-415
28. Mumcu G, Niazi S, Stewart J, Hagi-Pavli E, Gokani B, Seoudi N, Ergun T, Yavuz S, Stanford MR, Fortune F, Direskeneli H (2009) Oral health and related quality of life status in patients from UK and Turkey: a comparative study in Behçet's disease. J Oral Pathol Med 38:406-409
29. Mumcu G, Inanc N, Ergun T, Islek U, Yavuz S, Fresko I, Sur H, Atalay T, Direskeneli H (2004) Gender effects quality of life in Behçet's disease. Clin Exp Rheumatol 22(Suppl 34):S-86
30. Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR (2006) The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 21:1078-1085 (Pubitemid 44762726)
31. Siva A, Kantarci OH, Saip S, Altintas A, Hamuryudan V, Islak C, Kocer N, Yazici H (2001) Behçet's disease: diagnostic and prognostic aspects of neurologic involvement. J Neurol 248:95-103 (Pubitemid 32245418)
32. Moses Alder N, Fisher M, Yazici Y (2008) Behçet's syndrome patients have high levels of functional disability, fatigue and pain as measured by a Multi-dimensional Health Assessment Questionnaire (MDHAQ). Clin Exp Rheumatol 26(Suppl 50):S110-S113
33. Bodur H, Borman P, Ozdemir Y, Atan C, Kural G (2006) Quality of life and life satisfaction in patients with Behçet's disease: relationship with disease activity. Clin Rheumatol 25:329-333
34. Gilworth G, Chamberlain MA, Bhakta B, Haskard D, Silman A, Tennant A (2004) Development of the Behçet's disease quality of life, a quality of life measure specific to Behçet's disease. J Rheumatol 31:931-937 (Pubitemid 38585817)